Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation.
Children with Hurler syndrome (mucopolysaccharidosis type IH (MPSIH)) have skeletal, joint and soft tissue abnormalities that may persist or progress after hematopoietic stem cell transplantation (HSCT). We report our single center experience with development of carpal tunnel syndrome (CTS) in 43 children with MPSIH after HSCT. Twenty-three children (59%) developed CTS following HSCT; 19 of the 39 children with enzyme activity in the normal or heterozygous range developed CTS (49%), whereas all four children with low heterozygous or absent enzyme activity developed CTS after HSCT. Fourteen of 19 related donor marrow recipients, eight of 19 of those receiving an unrelated donor graft and one of five unrelated cord blood recipients developed CTS. The mean age at surgical release was 4.8 years. With each year increase in age at HSCT, there was a 55% increased risk. Age and enzyme activity after HSCT were significant factors in the development of CTS. Transplantation by 2 years of age reduced the risk of developing CTS by 46%; higher enzyme activity led to a 78% reduction in the risk of developing CTS. However, children transplanted for MPSIH remain at risk for the development of CTS, and should be monitored on an ongoing basis by nerve conduction velocity testing.
Khanna
G
G
Department of Orthopedic Surgery, University of Minnesota School of Medicine, Minneapolis, MN 55455, USA.
Van Heest
A E
AE
Agel
J
J
Bjoraker
K
K
Grewal
S
S
Abel
S
S
Krivit
W
W
Peters
C
C
Orchard
P J
PJ
D000367:Age Factors; D002349:Carpal Tunnel Syndrome / Q000209:etiology* / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007068:Iduronidase / Q000378:metabolism*; D053208:Kaplan-Meier Estimate; D008297:Male; D008059:Mucopolysaccharidosis I / Q000201:enzymology / Q000628:therapy*; D012189:Retrospective Studies; D012307:Risk Factors
D007068:Iduronidase